A unifying formalism to support automated synthesis of SBSTs for embedded caches

The paper presents a new unifying formalism introduced to effectively support the automatic generation of assembly test programs to be used as SBST (Software Based Self-Testing) for both data and instruction cache memories. In particular, the new formalism allows the description of the target memory, of the selected March Test algorithm, and the way this has to be customize to adapt it to the selected cache

Increasing the robustness of CUDA Fermi GPU-based systems

Nowadays Graphical processing Units (GPUs) have become increasingly popular due to their high computational power and low prices. This makes them particularly suitable for high-performance computing applications, like data elaboration and image processing. In these fields, the capability of properly work even in presence of faults is mandatory. This paper presents an innovative approach, that combines a Software Based Self Test & Diagnosis (SBSTD) methodology with a fault mitigation strategy, to increase the robustness of a CUDA Fermi GPU-based system

A software-based self test of CUDA Fermi GPUs

Nowadays, Graphical Processing Units (GPUs) have become increasingly popular due to their high computational power and low prices. This makes them particularly suitable for high-performance computing applications, like data elaboration and financial computation. In these fields, high efficient test methodologies are mandatory. One of the most effective ways to detect and localize hardware faults in GPUs is a Software-Based-Self-Test methodology (SBST). In this paper a fully comprehensive SBST and fault localization methodology for GPUs is presented. This novel approach exploits different custom test strategies for each component inside the GPU architecture. Such strategies guarantee both permanent fault detection and accurate fault localization

A cross-layer approach for new reliability-performance trade-offs in MLC NAND flash memories

In spite of the mature cell structure, the memory controller architecture of Multi-level cell (MLC) NAND Flash memories is evolving fast in an attempt to improve the uncorrected/miscorrected bit error rate (UBER) and to provide a more flexible usage model where the performance-reliability trade-off point can be adjusted at runtime. However, optimization techniques in the memory controller architecture cannot avoid a strict trade-off between UBER and read throughput. In this paper, we show that co-optimizing ECC architecture configuration in the memory controller with program algorithm selection at the technology layer, a more flexible memory sub-system arises, which is capable of unprecedented trade-offs points between performance and reliability

NBTI Mitigation by Dynamic Partial Reconfiguration

FPGAs achieve smaller geometries and their reliability is becoming a severe issue. Non-functional prop- erties, as Negative Bias Temperature Instability, affect the device functionality. In this work a novel methodology to address this issue is described, exploiting FPGAs flexibility. Dynamic Partial Reconfiguration is used to minimize aging impact on FPGAs’ configuration memory

MM2-thalamic Creutzfeldt-Jakob disease-Neuropathological, biochemical and transmission studies identify a distinctive prion strain

In Creutzfeldt-Jakob disease (CJD), molecular typing based on the size of the protease resistant core of the disease-associated prion protein (PrP(Sc) ) and the M/V polymorphism at codon 129 of the PRNP gene correlates with the clinico-pathologic subtypes. Approximately 95% of the sporadic 129MM CJD patients are characterized by cerebral deposition of type 1 PrP(Sc) and correspond to the classic clinical CJD phenotype. The rare 129MM CJD patients with type 2 PrP(Sc) are further subdivided in a cortical and a thalamic form also indicated as sporadic fatal insomnia. We observed two young patients with MM2-thalamic CJD. Main neuropathological features were diffuse, synaptic PrP immunoreactivity in the cerebral cortex and severe neuronal loss and gliosis in the thalamus and olivary nucleus. Western blot analysis showed the presence of type 2A PrP(Sc) . Challenge of transgenic mice expressing 129MM human PrP showed that MM2-thalamic sporadic CJD (sCJD) was able to transmit the disease, at variance with MM2-cortical sCJD. The affected mice showed deposition of type 2A PrP(Sc) , a scenario that is unprecedented in this mouse line. These data indicate that MM2-thalamic sCJD is caused by a prion strain distinct from the other sCJD subtypes including the MM2-cortical form

Synthetic prions with novel strain-specified properties

Prions are infectious proteins that possess multiple self-propagating structures. The information for strains and structural specific barriers appears to be contained exclusively in the folding of the pathological isoform, PrP(Sc). Many recent studies determined that de novo prion strains could be generated in vitro from the structural conversion of recombinant (rec) prion protein (PrP) into amyloidal structures. Our aim was to elucidate the conformational diversity of pathological recPrP amyloids and their biological activities, as well as to gain novel insights in characterizing molecular events involved in mammalian prion conversion and propagation. To this end we generated infectious materials that possess different conformational structures. Our methodology for the prion conversion of recPrP required only purified rec full-length mouse (Mo) PrP and common chemicals. Neither infected brain extracts nor amplified PrP(Sc) were used. Following two different in vitro protocols recMoPrP converted to amyloid fibrils without any seeding factor. Mouse hypothalamic GT1 and neuroblastoma N2a cell lines were infected with these amyloid preparations as fast screening methodology to characterize the infectious materials. Remarkably, a large number of amyloid preparations were able to induce the conformational change of endogenous PrPC to harbor several distinctive proteinase-resistant PrP forms. One such preparation was characterized in vivo habouring a synthetic prion with novel strain specified neuropathological and biochemical properties